Pain Management - Global Trends
Widespread availability of generic drugs, emergence of pain management clinics, and the advent of new drugs have accelerated the pace of growth in the pain management market. Healthcare reforms and reimbursement structure continue to shape demand for services, drugs and devices. The market is primarily driven by growing consumer demand, increase in people aged over 65, new surgical procedures, and product introductions.
Dynamics of the pain management pharmaceuticals market witnessed significant changes in recent years. The failure of several drugs, considered initially as promisingly curative including recent unsuccessful COX-2 inhibitors, prompted manufacturers and researchers to undertake more research programs. Drug delivery firms and larger pharmaceutical companies are undertaking partnerships by launching old therapies in new formulations. Partnerships among drug delivery firms and leading pharma companies are expected to produce tamper- and abuse-resistant novel drug innovations.
These and other market data and trends are presented in "Pain Management: Global Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
RELATED REPORTS
The raising of livestock is critical to world food production. Pest and disease control and general animal health aspects are gaining enhanced importance in animal management programs, which in turn predict a bright future for the veterinary vaccines market. Growth in veterinary vaccines market ove ...
Industries : Pharmaceutical
The fast developing small molecule chiral technology sector is witnessing a flurry of activity with pharmaceutical companies adding chiral expertise to their portfolios. Several leading pharmaceuticals such as Lipitor, Zocor, Advair, Norvasc and Viagra are chiral based. While conventional processes ...
Industries : Pharmaceutical, Biotechnology
The world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region has seen significant developments in the field ...
Industries : Pharmaceutical
Product descriptionThe present Competitive Intelligence Report about TGF-R agonists and antagonists provides a competitor evaluation in the field of transforming growth factor receptor (TGF-R) or TGF targeting molecules for tissue healing or treatment of cancer and fibrotic diseases of lung, skin o ...
Industries : Pharmaceutical
Product descriptionThe Competitive Intelligence Report Thrombopoiesis Stimulating Agents (TPO, IL-11) as of November 2009 provides information on thrombopoiesis stimulating agents targeting the thrombopoietin, interleukin-11 or other receptors on the market and in development.The product portfolio a ...
Industries : Pharmaceutical
The world anticoagulants market is driven by patent expiries, development of novel therapeutics, and rapidly aging population. With just two therapy classes - vitamin K antagonist and heparin injectables, dominating the market, there exist enormous opportunities and interest in developing advanced, ...
Industries : Pharmaceutical
World bulk paclitaxel market stands enthused by the effervescent levels of research and development. With market participants injecting resources into developing unique paclitaxel formulations, emergence of new disease indications is expected to result in expanded market opportunities in the medium ...
Industries : Pharmaceutical
Prevention of blindness has emerged into a top health priority among aging citizens in the developed countries. And increased healthcare spending in these countries is creating a strong demand for advanced ophthalmic therapeutic treatments. This in turn is leading to the rise in investments in ophth ...
Industries : Pharmaceutical
Global pharma industry faces numerous challenges in the form of increasing competition in generic markets, rising cost of new product development, declining research and development (R&D) productivity, shrinking average patent life, and mounting governmental pressure to reduce drug prices. Given th ...
Industries : Medical Equipment and Supply, Pharmaceutical
Alzheimer's disease (AD) and Parkinson's disease (PD) are the two important segments in neurodegenerative disorders market. These disorders represent unmet medical needs, as well as under diagnosed categories. However, this unmet requirement offers substantial opportunities for next generation thera ...
Industries : Pharmaceutical
Related industries
Related companies
reportlinker.com © Copyright 2009. All rights reserved